Designing a Novel Monitoring Approach for the Effects of Space Travel on Astronauts’ Health

This research paper discusses the development of an important tool that can help monitor astronauts' health while they are in space. Scientists created this assay kit, which includes about 20-30 genes known as DEGs (Differentially Expressed Genes), to quickly check on their wellbeing during missions like those aboard the International Space Station (ISS). The researchers wanted a way that was fast and easy for astronauts, so they focused only on certain changes in gene activity. They set some rules: if genes changed more than three times as active or less by about 95% confidence level, those were the ones to include in their kit (jlog2FCj¥3.00 and p< 0.05). However, they found that not all important health-related changes met these rules-specifically three genes called FGF18, ANGPTL7, and COMP were left out because their activity levels didn't change enough to be considered significant under the criteria set for this study.

The research paper presents the development of a rapid assay kit for monitoring astronauts' health conditions in space using differentially expressed genes (DEGs). This study aimed to identify DEGs that could serve as biomarkers reflecting physiological changes due to microgravity and other stressors associated with long-duration space missions. The methodology involved analyzing gene expression data from astronaut blood samples before, during, and after their stay on the International Space Station (ISS). The research team employed a stringent cutoff criteria of jlog2FCj≥3.00 for fold change in gene expression levels and p-values < 0.05 to identify DEGs relevant to astronaut health monitoring. Key findings revealed that the three genes FGF18, ANGPTL7, and COMP did not meet these criteria; hence they were excluded from consideration for inclusion in a rapid assay kit targeting spaceflight-related physiological changes.